BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21266946)

  • 1. Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia.
    Tiwari AK; Zai CC; Likhodi O; Voineskos AN; Meltzer HY; Lieberman JA; Potkin SG; Remington G; Müller DJ; Kennedy JL
    Pharmacogenomics J; 2012 Jun; 12(3):260-6. PubMed ID: 21266946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia.
    Tiwari AK; Zai CC; Likhodi O; Lisker A; Singh D; Souza RP; Batra P; Zaidi SH; Chen S; Liu F; Puls I; Meltzer HY; Lieberman JA; Kennedy JL; Müller DJ
    Neuropsychopharmacology; 2010 May; 35(6):1315-24. PubMed ID: 20107430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between polymorphisms in the cannabinoid receptor 1 gene, cognitive impairments and tardive dyskinesia in a Chinese population with schizophrenia.
    Lu C; Li S; Li Y; Zhang X; Chi J; Jiang Q; Ma Y; Shi X; Wang L; Li J
    Brain Res; 2023 Dec; 1821():148579. PubMed ID: 37739333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.
    Tiwari AK; Brandl EJ; Weber C; Likhodi O; Zai CC; Hahn MK; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
    J Clin Psychopharmacol; 2013 Feb; 33(1):11-7. PubMed ID: 23277265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of tardive dyskinesia with variation in CYP2D6: Is there a role for active metabolites?
    Koola MM; Tsapakis EM; Wright P; Smith S; Kerwin Rip RW; Nugent KL; Aitchison KJ
    J Psychopharmacol; 2014 Jul; 28(7):665-70. PubMed ID: 24595968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis.
    Miura I; Zhang JP; Nitta M; Lencz T; Kane JM; Malhotra AK; Yabe H; Correll CU
    Schizophr Res; 2014 Feb; 152(2-3):365-72. PubMed ID: 24411528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample.
    Zuo L; Kranzler HR; Luo X; Yang BZ; Weiss R; Brady K; Poling J; Farrer L; Gelernter J
    Neuropsychopharmacology; 2009 May; 34(6):1504-13. PubMed ID: 19052543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population.
    Bae JS; Kim JY; Park BL; Kim JH; Kim B; Park CS; Kim BJ; Lee CS; Lee M; Choi WH; Shin TM; Hwang J; Shin HD; Woo SI
    Psychiatr Genet; 2014 Oct; 24(5):225-9. PubMed ID: 25014618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.
    Zai CC; Hwang RW; De Luca V; Müller DJ; King N; Zai GC; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Kennedy JL
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):639-51. PubMed ID: 16959057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association analysis of polymorphisms in the N-methyl-D-aspartate (NMDA) receptor subunit 2B (GRIN2B) gene and tardive dyskinesia in schizophrenia.
    Liou YJ; Wang YC; Chen JY; Bai YM; Lin CC; Liao DL; Chen TT; Chen ML; Mo GH; Lai IC
    Psychiatry Res; 2007 Dec; 153(3):271-5. PubMed ID: 17669510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cannabinoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse.
    Zhang PW; Ishiguro H; Ohtsuki T; Hess J; Carillo F; Walther D; Onaivi ES; Arinami T; Uhl GR
    Mol Psychiatry; 2004 Oct; 9(10):916-31. PubMed ID: 15289816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the manganese superoxide dismutase gene Ala-9Val polymorphism with clinical phenotypes and tardive dyskinesia in schizophrenic patients.
    Liu H; Wang C; Chen PH; Zhang BS; Zheng YL; Zhang CX; Meng HQ; Wang Y; Chen DC; Xiu MH; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):692-6. PubMed ID: 20346996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of polymorphisms of IL10 and DBH was associated with general symptoms of PANSS with TD in Chinese Han schizophrenic patients.
    Sun H; Wang F; Fan H; Yan Q; Cui K; Yuan W; Zhao F; Zhao L; Yuan J; Yang F; Kosten TR; Zhang XY
    PLoS One; 2013; 8(8):e70963. PubMed ID: 23951054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study indicates a protective role of phosphatidylinositol-4-phosphate-5-kinase against tardive dyskinesia.
    Fedorenko OY; Loonen AJ; Lang F; Toshchakova VA; Boyarko EG; Semke AV; Bokhan NA; Govorin NV; Aftanas LI; Ivanova SA
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The catechol-O-methyl-transferase gene in tardive dyskinesia.
    Zai CC; Tiwari AK; Müller DJ; De Luca V; Shinkai T; Shaikh S; Ni X; Sibony D; Voineskos AN; Meltzer HY; Lieberman JA; Potkin SG; Remington G; Kennedy JL
    World J Biol Psychiatry; 2010 Sep; 11(6):803-12. PubMed ID: 20586531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain.
    Park YM; Choi JE; Kang SG; Koo SH; Kim L; Geum D; Lee HJ
    Hum Psychopharmacol; 2011; 26(4-5):332-7. PubMed ID: 21695734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia.
    Hamdani N; Tabeze JP; Ramoz N; Ades J; Hamon M; Sarfati Y; Boni C; Gorwood P
    Eur Neuropsychopharmacol; 2008 Jan; 18(1):34-40. PubMed ID: 17669634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible association between DBH 19 bp insertion/deletion polymorphism and clinical symptoms in schizophrenia with tardive dyskinesia.
    Hui L; Han M; Huang XF; Ye MJ; Zheng K; He JC; Lv MH; Zhang BH; Soares JC; Zhang XY
    J Neural Transm (Vienna); 2015 Jun; 122(6):907-14. PubMed ID: 25336319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia.
    Liou YJ; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Mo GH; Lai IC
    Am J Med Genet B Neuropsychiatr Genet; 2009 Mar; 150B(2):239-42. PubMed ID: 18548510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis.
    Clarke TK; Bloch PJ; Ambrose-Lanci LM; Ferraro TN; Berrettini WH; Kampman KM; Dackis CA; Pettinati HM; O'Brien CP; Oslin DW; Lohoff FW
    Addict Biol; 2013 Jul; 18(4):702-8. PubMed ID: 21790903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.